Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2018
Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis
Jimmy J Caudell, Matthew C Ward, Nadeem Riaz, et al.
Head & Neck
|
September 12, 2020
Evaluating compliance with process-related quality metrics and survival in oral cavity squamous cell carcinoma: Multi-institutional oral cavity collaboration study
Sara W Liu, Neil M Woody, Wei Wei, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 4, 2017
Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative
Matthew C Ward, Nadeem Riaz, Jimmy J Caudell, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 22, 2022
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer
Jimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, et al.
JAMA Oncology
|
April 20, 2023
Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial
Samuel Ryu, Snehal Deshmukh, Robert D Timmerman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2025
Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer - Results from xxxxx
Christina L Runge, Jessica A Lyness, Maura L Gillison, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 14, 2017
A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer
John A Vargo, Matthew C Ward, Jimmy J Caudell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2024
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non-Small Cell Lung Cancer
Feng-Ming Spring Kong, Chen Hu, Daniel A Pryma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2022
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Trisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
December 4, 2025
Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials
Laila A Gharzai, Emily Morris, Matthew J Schipper, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
International Journal of Radiation Oncology, Biology, Physics
|
February 8, 2018
Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis
Jimmy J Caudell, Matthew C Ward, Nadeem Riaz, et al.
Head & Neck
|
September 12, 2020
Evaluating compliance with process-related quality metrics and survival in oral cavity squamous cell carcinoma: Multi-institutional oral cavity collaboration study
Sara W Liu, Neil M Woody, Wei Wei, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 4, 2017
Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative
Matthew C Ward, Nadeem Riaz, Jimmy J Caudell, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 22, 2022
Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer
Jimmy J Caudell, Pedro A Torres-Saavedra, David I Rosenthal, et al.
JAMA Oncology
|
April 20, 2023
Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial
Samuel Ryu, Snehal Deshmukh, Robert D Timmerman, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2025
Self-Perceived Hearing Outcomes with Radiation and Cisplatin or Radiation and Cetuximab for Patients with HPV-Positive Oropharyngeal Cancer - Results from xxxxx
Christina L Runge, Jessica A Lyness, Maura L Gillison, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 14, 2017
A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer
John A Vargo, Matthew C Ward, Jimmy J Caudell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2024
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non-Small Cell Lung Cancer
Feng-Ming Spring Kong, Chen Hu, Daniel A Pryma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 26, 2022
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Trisha M Wise-Draper, Shuchi Gulati, Sarah Palackdharry, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
December 4, 2025
Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials
Laila A Gharzai, Emily Morris, Matthew J Schipper, et al.
Page
of 6